Moneycontrol PRO
Loans

business

Wockhardt gets USFDA warning for Morton Grove facility

The US drug regulator USFDA has issued a warning letter to the Mumbai-based pharma company Wockhardt for its Morton Grove facility in the country.

first published: Mar 7, 2017 10:38 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347